NPC
ACUR

National Planning Corporation’s Acura Pharmaceuticals ACUR Stock Holding History

National Planning Corporation’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,700
Closed -$4.83K – 2501
2014
Q4 		$4.83K Buy
+1,700
New +$4.7K ﹤0.01% 2334

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

National Planning Corporation's ACUR Position: Q1 2015 in Review

National Planning Corporation sold out of Acura Pharmaceuticals (ACUR) in Q1 2015, closing a stake of 1,700 shares — an estimated $4.83K sold.

National Planning Corporation first reported a position in ACUR in Q4 2014 and held it in 1 quarter. The position peaked at $4.83K in Q4 2014. 27 funds tracked by Wall St. Rank hold ACUR as of Q1 2015.

  • National Planning Corporation reported no remaining Acura Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 1,700 Acura Pharmaceuticals shares in Q1 2015, an estimated $4.83K.
  • National Planning Corporation first reported a position in Acura Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Acura Pharmaceuticals position peaked at $4.83K in Q4 2014.
  • 27 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.